Sugentech Inc
Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. The company offers lab tests, including systems and test items; and COVID-19 tests. It also provides point of care testing analyzers and test items for testing of influenza A/B, antibody test, COVID-19 and flu, SARS-CoV-2… Read more
Sugentech Inc (253840) - Total Assets
Latest total assets as of September 2025: ₩108.61 Billion KRW
Based on the latest financial reports, Sugentech Inc (253840) holds total assets worth ₩108.61 Billion KRW as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Sugentech Inc - Total Assets Trend (2017–2024)
This chart illustrates how Sugentech Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Sugentech Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Sugentech Inc's total assets of ₩108.61 Billion consist of 59.6% current assets and 40.4% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩10.57 Billion | 9.8% |
| Accounts Receivable | ₩2.28 Billion | 2.1% |
| Inventory | ₩6.12 Billion | 5.7% |
| Property, Plant & Equipment | ₩30.80 Billion | 28.6% |
| Intangible Assets | ₩1.28 Billion | 1.2% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2017–2024)
This chart illustrates how Sugentech Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sugentech Inc's current assets represent 59.6% of total assets in 2024, an increase from 41.4% in 2017.
- Cash Position: Cash and equivalents constituted 9.8% of total assets in 2024, down from 10.8% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2017.
- Asset Diversification: The largest asset category is property, plant & equipment at 28.6% of total assets.
Sugentech Inc Competitors by Total Assets
Key competitors of Sugentech Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Sugentech Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Sugentech Inc generates 0.09x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Sugentech Inc is currently not profitable relative to its asset base.
Sugentech Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 12.79 | 8.41 | 8.25 |
| Quick Ratio | 11.28 | 7.48 | 6.57 |
| Cash Ratio | 0.00 | 1.45 | 0.00 |
| Working Capital | ₩56.89 Billion | ₩ 53.51 Billion | ₩ 45.69 Billion |
Sugentech Inc - Advanced Valuation Insights
This section examines the relationship between Sugentech Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.07 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -19.2% |
| Total Assets | ₩107.64 Billion |
| Market Capitalization | $44.73 Million USD |
Valuation Analysis
Below Book Valuation: The market values Sugentech Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Sugentech Inc's assets decreased by 19.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Sugentech Inc (2017–2024)
The table below shows the annual total assets of Sugentech Inc from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩107.64 Billion | -19.18% |
| 2023-12-31 | ₩133.19 Billion | -23.15% |
| 2022-12-31 | ₩173.30 Billion | +11.40% |
| 2021-12-31 | ₩155.56 Billion | +114.70% |
| 2020-12-31 | ₩72.46 Billion | +59.52% |
| 2019-12-31 | ₩45.42 Billion | +86.36% |
| 2018-12-31 | ₩24.37 Billion | +33.35% |
| 2017-12-31 | ₩18.28 Billion | -- |